BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9652290)

  • 1. The stage is set for disease management and ESRD: can it succeed?
    Coutts LR; Neumann ME
    Nephrol News Issues; 1998 May; 12(5 Suppl):8. PubMed ID: 9652290
    [No Abstract]   [Full Text] [Related]  

  • 2. Re-engineering the ESRD Program amid Medicare reform.
    Neumann ME
    Nephrol News Issues; 2005 Jan; 19(2):40-1. PubMed ID: 15717573
    [No Abstract]   [Full Text] [Related]  

  • 3. Medicare HMOs reveal unique contracting strategies for new ESRD risk demonstration.
    Public Sect Contract Rep; 1997 May; 3(5):74-6. PubMed ID: 10174874
    [No Abstract]   [Full Text] [Related]  

  • 4. Bundling, and what is important for patients.
    Eilers D; LeBeau K
    Nephrol News Issues; 2009 Dec; 23(13):11. PubMed ID: 20050433
    [No Abstract]   [Full Text] [Related]  

  • 5. From fee-for-service to capitation: factors driving ESRD reimbursement system change.
    Day LM
    Nephrol News Issues; 1997 Apr; 11(4):22-3, 31. PubMed ID: 9287685
    [No Abstract]   [Full Text] [Related]  

  • 6. The direction of end-stage renal disease reimbursement in the United States.
    Lockridge RS
    Semin Dial; 2004; 17(2):125-30. PubMed ID: 15043614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overview of the Medicare and Medicaid programs.
    Health Care Financ Rev Stat Suppl; 1999; ():1-348. PubMed ID: 12847762
    [No Abstract]   [Full Text] [Related]  

  • 8. VillageHealth pleased with ESRD program.
    Dis Manag Advis; 2008 Oct; 14(10):suppl 3-4. PubMed ID: 19025163
    [No Abstract]   [Full Text] [Related]  

  • 9. Inadequate funding from payers will doom ESRD capitation.
    Day LM
    Nephrol News Issues; 1998 May; 12(5 Suppl):32, 34. PubMed ID: 9652299
    [No Abstract]   [Full Text] [Related]  

  • 10. Medicare demonstration project creeping to the starting line.
    Capitation Manag Rep; 2004 Oct; 11(10):109-11. PubMed ID: 15566118
    [No Abstract]   [Full Text] [Related]  

  • 11. Why we need the option of more dialysis.
    Hodge MH
    Nephrol News Issues; 2006 Oct; 20(11):76, 78-9. PubMed ID: 17039973
    [No Abstract]   [Full Text] [Related]  

  • 12. Cutting costs with disease management. CMS contractors guarantee 5 percent savings.
    Marietti C
    Healthc Inform; 2006 Feb; 23(2):106. PubMed ID: 16597025
    [No Abstract]   [Full Text] [Related]  

  • 13. Medicare Health Support program nearing its close.
    Dis Manag Advis; 2008 Jul; 14(7):MDM1-3. PubMed ID: 18683597
    [No Abstract]   [Full Text] [Related]  

  • 14. Dialysis outcomes in works. HCFA may set quality, practice guidelines for ESRD program.
    Gardner J
    Mod Healthc; 1997 Feb; 27(5):64-5. PubMed ID: 10164704
    [No Abstract]   [Full Text] [Related]  

  • 15. Carrier payment delays biggest problem for ESRD facilities.
    Paganini E
    Nephrol News Issues; 1990 Apr; 4(4):39-42. PubMed ID: 2333120
    [No Abstract]   [Full Text] [Related]  

  • 16. Will the bundle improve the way care is delivered?
    Neumann ME
    Nephrol News Issues; 2010 Jan; 24(1):8. PubMed ID: 20196495
    [No Abstract]   [Full Text] [Related]  

  • 17. HCFA: failing to acknowledge the unique characteristics of the ESRD patient.
    Kanter A; Nidetz M
    Nephrol News Issues; 1990 Feb; 4(2):23-6, 31. PubMed ID: 2320135
    [No Abstract]   [Full Text] [Related]  

  • 18. Medicare program; End Stage Renal Disease Program; responsibilities of network organizations--HCFA. Final rule.
    Fed Regist; 1988 Jan; 53(13):1617-20. PubMed ID: 10302132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In a bundling era, finding a fair price for ESRD services.
    Sullivan JD
    Nephrol News Issues; 2007 Mar; 21(4):37, 39-40. PubMed ID: 17393926
    [No Abstract]   [Full Text] [Related]  

  • 20. Report from the University Healthsystem Consortium.
    Int J Technol Assess Health Care; 1999; 15(2):437-8. PubMed ID: 10507201
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.